New 2026 Multisociety Guidelines for Atypical Breast Lesions and LCIS: What Clinicians Need to Know
Multisociety 2026 guidance clarifies diagnosis and management of atypical breast lesions and lobular carcinoma in situ, balancing excision, surveillance, and chemoprevention based on lesion type, radiologic concordance, and risk.
